Disease severity in moderate-to-severe plaque psoriasis: results from the Belgian REDISCOVER study

被引：0
|
作者：
Hillary, Tom [1 ]
Ghys, Liesbeth [2 ]
Willaert, Fabienne [3 ]
Swimberghe, Sandra
Lecuyer, Myriam
Ghislain, Pierre-Dominique [4 ]
Morrens, Joachim [2 ]
Lambert, Jo [5 ]
机构：
[1] Univ Hosp Leuven, Leuven, Belgium
[2] Abbvie Belgium, Brussels, Belgium
[3] Univ Libre Bruxelles, Erasme Hosp, Dermatol, Brussels, Belgium
[4] Catholic Univ Louvain, Dermatol, Clin St Luc, Brussels, Belgium
[5] Ghent Univ Hosp, Dermatol, Ghent, Belgium
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
40351
引用
收藏
页码：AB37 / AB37
页数：1
相关论文
共 50 条
  • [1] Disease severity in moderate-to-severe plaque psoriasis: Results from the Belgian REDISCOVER study
    Hillary, Tom
    Ghys, Liesbeth F. E.
    Willaert, Fabienne
    Swimberghe, Sandra
    Lecuyer, Myriam
    Ghislain, Pierre-Dominique
    Morrens, Joachim
    Lambert, Jo L. W.
    JEADV CLINICAL PRACTICE, 2024,
  • [2] Treatment patterns in moderate-to-severe plaque psoriasis: results from a Belgian cross-sectional study (DISCOVER)
    Lambert, Julien
    Ghislain, Pierre-Dominique
    Lambert, Jo
    Cauwe, Benedicte
    Van den Endend, Maria
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (05) : 394 - 400
  • [3] Risankizumab in moderate-to-severe plaque psoriasis
    Serrano, Linda
    Maloney, Victoria
    Gordon, Kenneth B.
    IMMUNOTHERAPY, 2019, 11 (16) : 1357 - 1370
  • [4] Treatment of moderate-to-severe plaque psoriasis
    Salgo, R.
    Thaci, D.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06): : 701 - 711
  • [5] Maintenance regimen of secukinumab in subjects with moderate-to-severe plaque psoriasis: Results from the OPTIMISE study
    Reich, Kristian
    Puig, Lluis
    Szepietowski, Jacek C.
    Paul, Carle
    Lacour, Jean Philippe
    Tsianakas, Athanasios
    Sieder, Christian
    Rissler, Michael
    Jagiello, Piotr
    Orsenigo, Roberto
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB90 - AB90
  • [6] Tildrakizumab: A Review in Moderate-to-Severe Plaque Psoriasis
    Frampton, James E.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (02) : 295 - 306
  • [7] The management of moderate-to-severe chronic plaque psoriasis
    Tonini, Annalisa
    Panduri, Salvatore
    D'Erme, Angelo M.
    Papadia, Francesca
    Romaneli, Marco
    Krueger, James G.
    Chiricozzi, Andrea
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2017, 152 (05): : 447 - 457
  • [8] Advances in the treatment of moderate-to-severe plaque psoriasis
    Herrier, Richard N.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (09) : 795 - 806
  • [9] Guselkumab for the treatment of moderate-to-severe plaque psoriasis
    Yang, Eric J.
    Sanchez, Isabelle M.
    Beck, Kristen
    Sekhon, Sahil
    Wu, Jashin J.
    Bhutani, Tina
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (04) : 333 - 344
  • [10] Guselkumab in the treatment of moderate-to-severe plaque psoriasis
    Lopez-Sanchez, Cristina
    Puig, Lluis
    IMMUNOTHERAPY, 2020, 12 (06) : 355 - 371
12345